Vicarious Surgical Inc. ( (RBOT) ) has released its Q1 earnings. Here is a breakdown of the information Vicarious Surgical Inc. presented to its investors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Vicarious Surgical Inc., a pioneering company in the field of next-generation robotics technology, is focused on transforming robotic surgery with its innovative single-port surgical system. Headquartered in Waltham, Massachusetts, the company aims to enhance surgical efficiency, improve patient outcomes, and reduce healthcare costs through its proprietary technology.
In its first quarter of 2025 financial results, Vicarious Surgical reported a slight decrease in operating expenses, with a total of $15.7 million compared to $16.1 million in the previous year. The company is on the brink of a significant milestone as it prepares to transition into a clinical-stage company, with plans to treat its first clinical patients later this year.
Key financial highlights include a reduction in research and development expenses to $9.4 million and a slight increase in general and administrative expenses to $5.3 million. The company reported an adjusted net loss of $15.3 million, consistent with the previous year, and a cash burn rate of $11.7 million for the quarter. As of March 31, 2025, Vicarious Surgical held $37.4 million in cash and investments.
Looking ahead, Vicarious Surgical anticipates a full-year cash burn of approximately $50 million. The company remains focused on the precise execution of its strategic goals as it advances towards clinical trials, with management expressing optimism about the upcoming transition to a clinical-stage entity.